confidential information

Confidential information in Italy

Check our article on this topic on Financier Worldwide: https://www.financierworldwide.com/confidential-information-in-italy#.XBoKs2hKg2w

By |19 12 2018|Uncategorized|0 Comments|

The Milan IP Court on the protection of confidential information and the unlawful solicitation of employees

With a preliminary decision of 26 February 2018, the IP Court of Milan recapped the principles governing unfair competition for the violation of confidential information and the unlawful solicitation of employees (docket no. 53629/18, Judge Mrs Giani). We recently mentioned a decision regarding a similar matter here on this […]

By |13 03 2018|Uncategorized|0 Comments|

Protection of confidential information: the Brescia IP Court confirms that bankrupt companies enjoy protection against unfair competition

(The original Italian version is published on Diritto24 – Il Sole 24 Ore)

A recent order by the IP Court of Brescia (Docket no. 16565/17, Judges Mr Del Porto, Mr Scaffidi and Mrs Agnese) confirmed that bankrupt companies enjoy protection against unfair competition. This is a particularly important ruling at […]

By |22 01 2018|Uncategorized|0 Comments|

The EMA adopts a new policy on the publication of clinical data: are IP rights at risk?

(The Italian version is also published on Diritto 14 – Il Sole 24 Ore)

On 2 October, the European Medicines Agency (“EMA”) adopted its new policy on the publication of clinical data for medicinal products for human use. The details of the policy, which will enter into force on 1 […]

By |30 10 2014|Uncategorized|0 Comments|

Ex-brokers, customer base and protection of confidential information (IP Court of Milan, Ruling no. 6579/2014)

A brokerage firm may not lawfully use information relating to the customers of its principal after the termination of the agency relationship, according to a recent ruling of the IP Court of Milan.

In the case decided by the Court of Milan, an insurance company sued one of its former […]

By |06 06 2014|Uncategorized|0 Comments|

EU General Court: EMA may not disclose clinical trials data

(by Francesca Maculan)

On 25 April, the President of the General Court of the European Union (“GC”) issued interim measures for suspension of operation of two decisions by the European Medicines Agency (“EMA”) granting third parties access to clinical trials data filed by pharmaceutical companies InterMune and AbbVie (jointly, the […]

By |27 06 2013|Uncategorized|0 Comments|